Men's health
Read more
| Service | Price estimate | Info |
|---|---|---|
| Kidney stone removal by ureteroscopy | from 8 977,00 € No Kela reimbursement Price estimate from 8 977,00 € No Kela reimbursement | |
| Ureteral stone removal by ureteroscopy | from 8 308,00 € No Kela reimbursement Price estimate from 8 308,00 € No Kela reimbursement | |
| Transurethral resection of bladder | 7 255,00 € No Kela reimbursement Price estimate 7 255,00 € No Kela reimbursement | |
| Transurethral resection of prostate | 8 411,00 € No Kela reimbursement Price estimate 8 411,00 € No Kela reimbursement | |
| Transurethral incision of prostate | 4 476,00 € No Kela reimbursement Price estimate 4 476,00 € No Kela reimbursement | |
| Prostate laser vaporization | from 5 756,00 € No Kela reimbursement Price estimate from 5 756,00 € No Kela reimbursement | |
| Hydrocelectomy | 3 469,00 € No Kela reimbursement Price estimate 3 469,00 € No Kela reimbursement | |
| Spermatocelectomy | 3 469,00 € No Kela reimbursement Price estimate 3 469,00 € No Kela reimbursement | |
| Vasectomy under general anaesthesia | from 900,00 € No Kela reimbursement Price estimate from 900,00 € No Kela reimbursement | |
| Vasovasostomy | 4 901,00 € No Kela reimbursement Price estimate 4 901,00 € No Kela reimbursement | |
| Circumcision under general anaesthesia | 2 926,00 € No Kela reimbursement Price estimate 2 926,00 € No Kela reimbursement |
Revised 10/16/2026
Published 10/16/2026
Minimally invasive treatments can relieve urinary symptoms caused by prostate hyperplasia without conventional surgery. The minimally invasive treatment options available in Finland include Rezūm water vapour therapy and iTind treatment.
Unlike traditional surgical treatments, such as transurethral resection of the prostate (TURP), hyperplastic tissue is not removed by resecting. The treatments are performed through the urethra without external surgical incisions, and they can be performed under local anaesthesia.
The goal of minimally invasive treatments is to facilitate the flow of urine and reduce urinary symptoms without more extensive surgery. The suitability of the treatment method is always evaluated individually.
Minimally invasive treatment can be considered, for example, when:
The suitability of the treatment is influenced by, among other things, the size and shape of the prostate, the severity of symptoms, urinary bladder function, the amount of residual urine, previous medical treatment and its effect, as well as general health and the patient's own wishes.
A large prostate, severe urinary symptoms, recurrent urinary retention, or another additional problem related to urination may lead to the selection of another form of treatment, such as resection or incision of the prostate.
You will receive individual instructions on preparing. Current medications and other factors affecting the operation will be reviewed before the treatment.
Rezūm and iTind are performed under local anaesthesia. If necessary, other pain relief can also be used, such as inhaled pain medication.
Rezūm water vapor therapy: The urologist administers small amounts of water vapor to the overgrown prostate tissue. As a result of the treatment, the treated tissue gradually shrinks.
iTind: The urologist places a temporary treatment device in the prostate area. The device reshapes the area of the urethra and bladder neck, aiming to facilitate the flow of urine.
The procedure time is usually short.
After Rezūm, a urinary catheter is usually used for about a week. The catheter helps ensure the flow of urine during swelling after the operation.
In iTind treatment, the treatment device is in place for about a week. The urologist removes the device at a follow-up appointment.
Recovery is individual, but after minimally invasive treatments, discharge is usually quick and you can return to everyday life quite soon. However, transient symptoms may occur after operations, such as a burning sensation when urinating, increased urinary frequency, or urgency.
Other possible symptoms include slight blood in the urine as well as pain or a feeling of pressure in the pelvic or perineal area. A urinary tract infection or urinary retention is also possible.
Upon discharge, you will receive individual instructions regarding, among other things, medication, physical exertion, and follow-up appointment. Medication for benign prostatic hyperplasia should not be stopped on your own; instead, continuing or discontinuing it is agreed upon with a urologist.
After Rezūm, urinary symptoms may initially even worsen due to swelling caused by the treatment. Difficulty urinating may lead to a temporary need for a catheter.
Relief of symptoms occurs gradually, and the full effect of the treatment usually develops over the coming weeks and months.
After iTind, while the device is in place, urination may feel abnormal, and pressure or discomfort may occur in the pelvic area.
Urination may become easier after the removal of the device, and the effect of the treatment may strengthen over the following weeks.
Upon discharge, you will receive individual instructions on the types of situations in which you should contact the treatment facility.
Contact may be necessary, for example, if:
The thread intended for the removal of the iTind device must not be pulled, cut, or damaged. If the thread is damaged or the device comes loose, contact the treatment facility.
Treatments can provide long-term relief from symptoms, but they do not prevent the possible subsequent growth of the prostate. Some patients may later require medication or a new operation.
The treatment forms are relatively new, so there is less research data on their very long-term results than on established surgical treatments.
The risk of adverse effects on sexual function may be lower than in some tissue-removing surgical treatments. However, the risk is not completely excluded, and possible effects are reviewed before the operation.
The effect of minimally invasive treatments may not necessarily be felt immediately, but relief of symptoms occurs at different rates depending on the form of treatment.
Rezūm: The effect usually develops gradually over weeks and months as the treated prostate tissue shrinks.
iTind: Urination may become easier after the removal of the device, and the effect may strengthen over the following weeks.
Medication should not be stopped on one's own. A physician assesses whether medication is still needed and when its possible discontinuation or reduction can be considered.
There is no single best form of treatment suitable for everyone. The advantage of minimally invasive treatments can be a lighter operation and a lower risk of certain sexual adverse effects. On the other hand, their effect may develop more slowly, and there is less research evidence on long-term effectiveness than on established surgical treatments.
Based on examinations, a urologist will assess which form of treatment is best suited to your specific situation.
